期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
产普鲁兰酶菌株的筛选鉴定及普鲁兰酶基因的克隆表达及其性质分析 被引量:1
1
作者 郭晓敏 李宁 +5 位作者 唐玉 路卫卫 李伟亮 董宇辰 陆坚 黄日波 《基因组学与应用生物学》 CAS CSCD 北大核心 2021年第9期3035-3043,共9页
本研究从广西防城港市北仑河口红树林土壤沉积物中筛选到1株产普鲁兰酶细菌GXM-1,利用形态学和16S rRNA序列进行分析鉴定,结果表明该菌株为Bacillus licheniforms;采用同源克隆策略获得了Bacillus licheniforms GXM-1普鲁兰酶基因(pulM)... 本研究从广西防城港市北仑河口红树林土壤沉积物中筛选到1株产普鲁兰酶细菌GXM-1,利用形态学和16S rRNA序列进行分析鉴定,结果表明该菌株为Bacillus licheniforms;采用同源克隆策略获得了Bacillus licheniforms GXM-1普鲁兰酶基因(pulM),在Escherichia coli BL21中实现了pulM的可溶性表达。纯化普鲁兰酶的比活力为72.6 U/mg,最适反应温度为40℃,最适p H为6.5,K_(m)=(6.442±0.4668)mg/mL,V_(max)=(89.84±2.795)μmol·min^(-1)·mg^(-1),40℃保温4 h相对残余酶活力为40%,在pH 7.0~8.0缓冲液中保存12 h,相对残余酶活力保持在80%以上,金属离子Ca^(2+)、Na^(+)、Li^(+)和Ni^(+)对PulM的酶活力有明显的激活作用。研究结果为普鲁兰酶在工业中的应用研究提供了新的思路。 展开更多
关键词 普鲁兰酶 筛选鉴定 基因克隆 重组表达 酶学性质
原文传递
Closed-loop transfer brightens up artificial intelligence for chemistry
2
作者 Qipeng Li Mengyun Chen Tiankai Zhang 《Green Carbon》 2025年第2期158-159,共2页
Artificial intelligence(AI)has undergone rapid development and has become increasingly involved in scientific explorations[1].It not only successfully facilitates the efficient completion of previous labor-intensive a... Artificial intelligence(AI)has undergone rapid development and has become increasingly involved in scientific explorations[1].It not only successfully facilitates the efficient completion of previous labor-intensive and time-consuming tasks,including literature review,compound screening,and data analysis,but also guides closed-loop experiments for target functions optimization[2].However,the potential of AI for uncovering new chemical knowledge remains largely untapped[3]. 展开更多
关键词 uncovering new chemical knowledge scientific explorations closed loop transfer CHEMISTRY data analysisbut artificial intelligence ai literature reviewcompound screeningand artificial intelligence
在线阅读 下载PDF
Integrated Cross-Scale Manipulation and Modulable Encapsulation of Cell-Laden Hydrogel for Constructing Tissue-Mimicking Microstructures
3
作者 Yanfeng Zhao Xinyi Dong +5 位作者 Yang Li Juan Cui Qing Shi Hen-Wei Huang Qiang Huang Huaping Wang 《Research》 2025年第1期704-717,共14页
Engineered microstructures that mimic in vivo tissues have demonstrated great potential for applications in regenerative medicine,drug screening,and cell behavior exploration.However,current methods for engineering mi... Engineered microstructures that mimic in vivo tissues have demonstrated great potential for applications in regenerative medicine,drug screening,and cell behavior exploration.However,current methods for engineering microstructures that mimic the multi-extracellular matrix and multicellular features of natural tissues to realize tissue-mimicking microstructures in vitro remain insufficient.Here,we propose a versatile method for constructing tissue-mimicking heterogeneous microstructures by orderly integration of macroscopic hydrogel exchange,microscopic cell manipulation,and encapsulation modulation.First,various cell-laden hydrogel droplets are manipulated at the millimeter scale using electrowetting on dielectric to achieve efficient hydrogel exchange.Second,the cells are manipulated at the micrometer scale using dielectrophoresis to adjust their density and arrangement within the hydrogel droplets.Third,the photopolymerization of these hydrogel droplets is triggered in designated regions by dynamically modulating the shape and position of the excitation ultraviolet beam.Thus,heterogeneous microstructures with different extracellular matrix geometries and components were constructed,including specific cell densities and patterns.The resulting heterogeneous microstructure supported long-term culture of hepatocytes and fibroblasts with high cell viability(over 90%).Moreover,the density and distribution of the 2 cell types had significant effects on the cell proliferation and urea secretion.We propose that our method can lead to the construction of additional biomimetic heterogeneous microstructures with unprecedented potential for use in future tissue engineering applications. 展开更多
关键词 cell behavior explorationhowevercurrent tissue mimicking microstructures cell laden hydrogel electrowetting dielectric regenerative medicinedrug screeningand heterogeneous microstructures engineered microstructures orderly integration
原文传递
Microfluidic platforms for monitoringcardiomyocyte electromechanical activity
4
作者 Wei Wang Weiguang Su +5 位作者 Junlei Han Wei Song Xinyu Li Chonghai Xu Yu Sun Li Wang 《Microsystems & Nanoengineering》 2025年第1期23-44,共22页
Cardiovascular diseases account for ~40% of global deaths annually. This situation has revealed the urgent need forthe investigation and development of corresponding drugs for pathogenesis due to the complexity of res... Cardiovascular diseases account for ~40% of global deaths annually. This situation has revealed the urgent need forthe investigation and development of corresponding drugs for pathogenesis due to the complexity of researchmethods and detection techniques. An in vitro cardiomyocyte model is commonly used for cardiac drug screeningand disease modeling since it can respond to microphysiological environmental variations through mechanoelectricfeedback. Microfluidic platforms are capable of accurate fluid control and integration with analysis and detectiontechniques. Therefore, various microfluidic platforms (i.e., heart-on-a-chip) have been applied for the reconstruction ofthe physiological environment and detection of signals from cardiomyocytes. They have demonstrated advantages inmimicking the cardiovascular structure and function in vitro and in monitoring electromechanical signals. This reviewpresents a summary of the methods and technologies used to monitor the contractility and electrophysiologicalsignals of cardiomyocytes within microfluidic platforms. Then, applications in common cardiac drug screening andcardiovascular disease modeling are presented, followed by design strategies for enhancing physiology studies. Finally,we discuss prospects in the tissue engineering and sensing techniques of microfluidic platforms. 展开更多
关键词 cardiac drug screeningand detection techniques microfluidic platforms investigation development corresponding drugs pathogenesis disease modeling accurate fluid control cardiovascular diseases vitro cardiomyocyte model
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部